APUS vs MSFT: Which Stock is Better?
Side-by-side comparison of Apimeds Pharmaceuticals US, Inc. and Microsoft Corporation in 2026
APUS
Apimeds Pharmaceuticals US, Inc.
$3.54
MSFT
Microsoft Corporation
$495.83
Key Metrics Comparison
| Metric | APUS | MSFT | Winner |
|---|---|---|---|
| Market Cap | $2.36M | $3.71T | MSFT |
| P/E Ratio | N/A | 33.89 | APUS |
| EPS (TTM) | $N/A | $14.08 | MSFT |
| Revenue Growth | 0.0% | 18.4% | MSFT |
| Gross Margin | 0.0% | 67.9% | MSFT |
Analyze APUS
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is APUS or MSFT a better investment?
Comparing APUS and MSFT: Apimeds Pharmaceuticals US, Inc. has a market cap of $2.36M while Microsoft Corporation has $3.71T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between APUS and MSFT?
APUS (Apimeds Pharmaceuticals US, Inc.) and MSFT (Microsoft Corporation) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: APUS or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: APUS or MSFT?
MSFT has higher revenue growth at 18.4% vs 0.0% for APUS.
Which company is more profitable: APUS or MSFT?
Microsoft Corporation (MSFT) has higher gross margins at 67.9% compared to 0.0% for APUS.
Which is the larger company: APUS or MSFT?
Microsoft Corporation (MSFT) is larger with a market cap of $3.71T compared to $2.36M for APUS.
Should I buy APUS or MSFT in 2026?
Both APUS and MSFT have investment merit. APUS trades at $3.54 while MSFT trades at $495.83. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between APUS and MSFT stock?
Key differences: Market Cap ($2.36M vs $3.71T), P/E Ratio (N/A vs 33.9x), Revenue Growth (0.0% vs 18.4%), Gross Margin (0.0% vs 67.9%).
Should I buy APUS or MSFT in 2026?
The choice between APUS and MSFT depends on your investment goals. MSFT shows higher revenue growth (18.4%). MSFT has better margins (67.9%). Consider your risk tolerance and time horizon.
What is the market cap comparison between APUS and MSFT?
APUS (Apimeds Pharmaceuticals US, Inc.) has a market cap of $2.36M, while MSFT (Microsoft Corporation) has a market cap of $3.71T. MSFT is the larger company by market value.